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Zinc half sites are present in all human lactogenic hormones: human prolactin (hPRL), growth hor-
mone (hGH), placental lactogens (hPL) and the hPRL receptor (hPRLr). The inﬂuence of divalent zinc
(Zn2+) as measured by intrinsic ﬂuorescence or FRET in each of these hormones is unique and is
affected by the presence of varying stoichiometries of hPRLr. These data show that both Zn2+ and
hPRLr binding inﬂuence hPRL conformers in an interdependent fashion. Although each of these
three lactogenic hormones bind hPRLr and induce a biological response that is sensitive to the pres-
ence of increasing concentrations of Zn2+, each hormone is unique in the mechanistic details of this
process.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction hPRLr [3]. Finally, the binding of hPRL to hPRLr is modestly dimin-We have previously shown that three structurally similar hor-
mones: human prolactin (hPRL), growth hormone (hGH), and pla-
cental lactogen (hPL), undergo a conformation change when
binding the extracellular domain of the hPRL receptor (hPRLr)
[1]. Divalent zinc (Zn2+) binds a half-site in hPRL, hGH, and hPL
[1–3] as well as a second half-site in hPRLr. Depending on the mea-
sured end point (cellular binding, site 1 binding, biological activ-
ity), lM concentrations of Zn2+ dramatically change hGH binding
to the hPRL receptor [1,4,5] but has little or no effect on hGH bind-
ing to the hGH receptor. Zn2+ is required for hPL binding to thechemical Societies. Published by E
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, United States.ished by the presence of Zn2+ [1].
Zn2+ binding will link helices 1 and 4 restricting movements to
conformations either more or less favorable for hPRLr binding or
biological activity. Binding hPRLr at site 1of each hormone provides
a second half site for Zn2+ and may inﬂuence Zn2+ binding or the
stability of the protein complex. In this work we investigate the
comparative effects of the presence or absence of Zn2+ on hPRL,
hGH, hPL, and hPRLr and the interactions of these hormones with
hPRLr by intrinsic ﬂuorescence, Förster resonance energy transfer
(FRET), and in vivo cellular assays in order to describe the effects
of Zn2+ on hormone structure and function.
2. Materials and methods
2.1. Preparation of expression vectors
The pT7-7 phagemid expression vectors for methionyl hPRL,
hGH and the extracellular domain of the human hPRL receptor
(hPRLr, residues 1–224) were prepared as described [1]. hPL cDNA
from the I.M.A.G.E. Consortium (LLNL) cDNA Clones [6] was pur-
chased from Open Biosystems (Huntsville, AL) and cloned into
pET-28b(+) (Novagen, EMD Chemicals, Darmstadt, Germany). Thelsevier B.V. All rights reserved.
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adine tag and a portion of the poly-cloning site. The hPL cDNA was
ampliﬁed by PCR using a primer that added a methionyl codon
immediately to the N-terminus of the mature protein and a second
primer that added a Hind III site 30 to the stop codon of hPL. The
PCR product was characterized, double digested with Nco I and
Hind III, and ligated into the linearized and modiﬁed pET28b(+)
plasmid. The hPL expression vector was expanded in XL-10 Gold
cells (Stratagene, Cedar Creek, TX) selected by kanamycin resis-
tance, puriﬁed, and stored in water at 4 C.
2.2. Mutagenesis
Mutations in the hormones were performed either by the
method of Kunkel [7] or by the quick change method (Stratagene)
[8]. M158C hPRL, N152C hGH, and N152C hPL by procedures de-
scribed in [1]. We refer to the N-terminal methionyl residue as
residue 0, so the sequence numbering corresponds to that of ma-
ture proteins.
2.3. Protein expression and puriﬁcation
Expression of the various proteins was performed in BL20 (DE3)
Escherichia coli (Novagen). All proteins were expressed as described
by Peterson et al. [9] and Voorhees and Brooks [1]. Protein concen-
trations were determined by the bicinchroninic assay using bovine
albumin as a standard [10] or by the calculated molar extinction
coefﬁcients (e280 nm) [11]: hPRL = 21805 cm1 M1, hGH = 17670
cm1 M1, hPL = 17670 cm1 M1, and ex-hPRLr = 66140 cm1
M1.
2.4. Labeling of hormones with CPM or OG
Hormones (hPRL M158C, hGH N152C, and hPL N152C) contain-
ing a free cysteine distal from either the Zn2+ or receptor binding
sites were labeled with 7-diethylamino-3-(40-maleimidylphenyl)-
4-methylcoumarin (CPM, Cat# D-346) or 20-70-diﬂuoroﬂuoresce-
in-5-malamide (OG, Cat# O-6034) (Invitrogen, Carlsbad, CA) as
previously described [1]. CPM-labeled proteins were used within
24–48 h.
2.5. Measurement of intrinsic ﬂuorescence
One micromolar concentrations of wild-type hPRL, hGH, hPL, or
hPRLr were prepared in 150 mM NaCl, 10 mM Tris, pH 7.4 with
varying concentrations (0–40 lM) of ZnSO4 or Na2SO4 and allowed
to reach equilibrium by incubating in darkness at room tempera-
ture for one hour. Samples were illuminated at 295 nm using a
Varian–Cary Eclipse ﬂuorescence spectrophotometer (Varian, Inc.,
Palo Alto, CA) and emission spectra recorded from 300 to 450 nm
[12].
2.6. Zinc titration of various hormone/hPRLr stoichiometries
determined by FRET
Unlabeled and either CPM- or OG-labeled wild-type hormones
were mixed in 10 mM Tris, pH 7.4, and 150 mM NaCl to obtain
1 lM concentrations and ﬂuorescence intensities appropriate for
FRET or control studies, respectively. Varying concentrations (0–
25 lM) of either ZnSO4 or Na2SO4 were added to the proteins
and allowed to bind for 1 hour in the dark at room temperature.
Additional sets of CPM-labeled hormones with increasing Zn2+ con-
centrations were combined with various concentrations of hPRLr
to obtain 1:0.2, 1:1, and 1:5 ratios. Samples were illuminated at
295 nm using a Varian–Cary Eclipse ﬂuorescence spectrophotome-
ter and emission spectra recorded from 300 to 550 nm. Finally con-trol experiments binding OG-labeled hormones with or without
15 lM Zn2+ were performed to determine the effects on the ﬂuo-
rescence within the vicinity of the extrinsic OG ﬂuorochrome inde-
pendent of FRET coupling.
2.7. Cellular assays for lactogenic activity
FDC-P1 cells stably expressing the human prolactin receptor
were provided by Genentech, Inc. (San Francisco, CA) and main-
tained as previously described [2]. Hormone dose-response studies
were performed as previously described [13] using a vital dye
method (Alamar Blue, Biomed, Cleveland, OH) [14].
2.8. TPEN toxicity
FDC-P1 cells were maintained as described and supplemented
with no supplement or with 2 lM N,N,N0,N0-tetrakis(2-pyridyl-
methyl)ethylenediamine (TPEN) (Invitrogen)(15). Cells were
stained with Trypan Blue at 0, 24, 36, and 48 h and hemocytome-
teric cell counts recorded total cell count as well living versus dead
cells.
Each experiment was performed at least three times. Each
experimental replicate provided consistent similar results.3. Results
3.1. Characterization of recombinant proteins
Wild-type and mutant hPRL, hGH, hPL, and wild-type hPRLr
were prepared. Each protein was characterized by SDS-containing
polyacrylamide gel electrophoresis under reducing conditions and
was noted to be >95% homogeneous and run at the appropriate
molecular weight (data not shown).
3.2. Effect of Zn2+ on the intrinsic ﬂuorescence of hPRL, hGH, hPL, and
hPRLr
The addition of Zn2+ to hPRL increased the ﬂuorescence inten-
sity at 340 nm (Fig. 1). These spectra indicate that the binding of
Zn2+ to hPRL induces a signiﬁcant change in the environment of
one or both tryptophans and are consistent with changes in hPRL’s
conformation. Parallel titrations with Na2SO4 showed no changes
in ﬂuorescence, thus the change of hPRL ﬂuorescence is attributed
to the presence of Zn2+. In contrast, ZnSO4 titrations performed
with either hGH or hPL showed little or no change in the intrinsic
ﬂuorescence when compared to control Na2SO4 titrations. These
data provide no evidence of a zinc-induced conformation change
but do not rule out conformation changes. Finally, although hPRLr
contains nine tryptophans, including two tryptophans close to the
receptor’s Zn2+ binding site (D187 and H188), Zn2+ titration did not
change the intrinsic ﬂuorescence of hPRLr. This observation sug-
gests that Zn2+ concentrations up to 40 lM did not inﬂuence the
conformation of the extracellular domain of the hPRL receptor.
The two adjacent residues comprising the receptor’s Zn2+ half site
are unlikely to induce a conformation change because binding does
not bring distant residues into proximity inducing signiﬁcant
structural change.
3.3. Effect of Zn2+ on FRET of hPRL, hGH, and hPL
In the absence of Zn2+ increased ratios of hPRLr to hormone pro-
duced increases in FRET (Fig. 2 and Supplementary Fig. 1). The pat-
tern of each hormones’ hPRLr-mediated increased FRET signal was
unique suggesting distinct differences in the receptor binding
mechanisms for each hormone.
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Fig. 1. Zn2+ dependence of intrinsic ﬂuorescence of lactogenic hormones and the extracellular domain of the hPRL receptor. Wild-type hPRL (row A), hGH (row B), hPL (row C),
or hPRLr (row D). One micromolar proteins in 150 mM NaCl, 10 mM Tris, pH 7.4 and varying concentrations (0–40 lM) of Na2SO4 (left column) or ZnSO4 (right column) were
excited at 295 nm and emissions recorded between 300 and 450 nm. One of three independent experiments.
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(Fig. 2, Supplementary Table 1); an indication that on average
Zn2+ binding brought the tryptophans closer to the CPM. Neither
hGH nor hPL showed changes in FRET when titrated with Zn2+ in
the absence of hPRLr (Fig. 2 left column, Table 1). In addition
titrations with up to Na2SO4 did not change the FRET signalfor any of the three hormones. These results provide a conclu-
sion similar to that of intrinsic ﬂuorescence measurements; hPRL
undergoes a Zn2+-induced change in conformation while these
methods do not provide evidence of a similar change for either
hGH or hPL despite a demonstrated Zn2+-dependent change in
function.
Fig. 2. Zn2+-dependence of FRET spectra from lactogenic hormones in the absence or presence of hPRLr. hPRL (row A), hGH (row B), and hPL (row C) solutions were prepared
in 150 mM NaCl, 10 mM Tris, pH 7.4 with varying concentrations of NaSO4 (left column) or ZnSO4 (0–25 lM, right columns) and increasing stoichiometries of hPRLr (1:0,
1:0.2, 1:1, and 1:5), excitation 295 nm and emission 300–550 nm. One of three independent experiments.
Table 1
ED50 for lactogen-stimulation of growth with varying concentrations of Zn2+.
Zn2+ concentrations (nM) Zn2+-dependent increase
in ED50 (1–16 lM)
0 lM 1 lM 16 lM
hPRL N/A⁄ 0.85 0.81 0.95
hGH N/A⁄ 0.33 0.06 5.50
hPL N/A⁄ 26.68 10.10 2.64
⁄ Not applicable, no cell growth observed without Zn2+.
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stoichiometries and titrated with Zn2+, the FRET signals for each
hormone were unique (Figs. 2 and Supplementary Fig. 2). These re-
sults suggested that binding of both Zn2+ and hPRLr inﬂuenced
each hormone’s conformation in a complex fashion and were un-
ique for each hormone. In the case of hPRL the Zn2+-dependent
FRET signal is increased by up to 1:1 hPRLr/hPRL stoichiometries.
At a 1:5 stoichiometry the Zn2+-dependent FRET signal is reduced.
These changes suggest that the inﬂuence of Zn2+ on the conforma-
tion of hPRL is not only changed by the ﬁrst hPRLr binding but is
further changed (in an opposite direction) by the binding of the
second hPRLr.
When hGH bound either equivalent or excess stoichiometries of
hPRLr, Zn2+ induced an increase in hGH FRET signal up to a 1:1 stoi-
chiometry, but higher stoichiometries produced little further in-
creases in FRET. These results suggest that in the absence of
receptor, Zn2+ does not change the conformation of hGH, but when
site 1 is bound by hPRLr, Zn2+ inﬂuences hGH’s conformation as
evidenced by tryptophan approaching the CPM reporter. This
change is associated with an increased afﬁnity of hGH for hPRLr
at site 1 [1]. Binding hPRLr at site 2 is not associated with further
changes in Zn2+-induced hGH FRET.
Finally, Zn2+-dependent changes in the hPL FRET signal were not
inﬂuenced by the presence of up to equal molar stoichiometries of
hPRLr, but when higher hPRLr stoichiometries (1:5, hPL:hPRLr)were present titration of Zn2+ produces a modest increase in the
FRET signal indicating a Zn2+-dependent change in hPL conforma-
tion when bound by hPRLr concentrations able to saturate both
sites 1 and 2 (Figs. 2 and Supplementary Fig. 2).
The lactogens might provide a false-positive FRET signal if Zn2+
binding altered the environment surrounding the extrinsic ﬂuoro-
chrome and changed the efﬁciency of the CPM reporter. We cova-
lently linked OG, a non-FRET ﬂuorochrome, to the same location as
we had previously linked the CPM reporter. When OG replaced
CPM the ability of tryptophan to transfer energy to OG was elimi-
nated (data not shown). Thus, OG ﬂuorescence served as a sensitive
probe for changes in the extrinsic ﬂuorochrome’s environment.
Fluorescence spectra (Supplemental Fig. 3) collected for each lacto-
gen showed a similar pattern where the presence of 15 lM Zn2+
produced a modest decrease in OG ﬂuorescence, an effect opposite
to the Zn2+-induced increase in CPM ﬂuorescence observed in our
FRET experiments. These results indicate that the small negative
changes in the environment of the extrinsic ﬂuorochrome could
not account for the larger positive changes observed in FRET exper-
iments, but the Zn2+-dependent local quenching will inﬂuence
FRET making a quantitative analysis ambiguous.
3.4. Biological assays
FDC-P1 cells transfected with the human prolactin receptor
were assayed without (1 lM endogenous Zn2+) or with the addi-
tion of 15 lM ZnSO4 (Fig. 3, Table 1).
The addition of 15 lM Zn2+ did not inﬂuence the ED50 of the
hPRL bioassay. In contrast, the addition of Zn2+ to the hGH bioassay
increased the biological activity of hGH by reducing the ED50 by
ﬁvefold. The ED50 for hGH is several-fold less than that of hPRL. Fi-
nally, the supplementation of the endogenous Zn2+ with 15 lM
Zn2+ reduced the hPL ED50 twofold. The ED50s of hPL was between
16- and 33-fold greater than that of hPRL.
We attempted to reduce free Zn2+ concentrations by addition of
TPEN, a high afﬁnity chelator of Zn2+ [15]. Addition of 2 lM TPEN
Fig. 3. Effect of increased Zn2+ concentrations on the biological activity of human prolactin. Biological assays assessing the cytokine-induced response were performed in the
presence of increasing concentrations of hPRL in media supplemented with 2 lM TPEN (left), no supplementation (center), or 15 lM ZnSO4 supplementation (right). One of
two independent experiments. Signiﬁcant changes in ED50s are achieved with a two to threefold change in value.
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tration of TPEN for up to 48 h did not affect cell viability as deter-
mined by trypan blue dye exclusion or by the cells ability to
replicate (data not shown). But when hPRL-stimulated cellular pro-
liferation was measured by the Alamar Blue vital dye method the
basal rate of resazurin reduction [14] was reduced and hPRL failed
to effect cellular proliferation despite our knowledge that Zn2+ is
not required for hPRL binding to the hPRLr (Fig. 3). Zn2+ is critical
to numerous cellular processes and it appears that treatment of
cells with TPEN removes the intracellular pool of Zn2+ leaving the
cells unable to respond to lactogenic hormones. Based on these re-
sults we could not determine the effects of Zn2+ reduction on
in vivo lactogen action.
4. Discussion
hPRL receptor binding kinetics for each of the three human lac-
togenic hormones previously was shown to be inﬂuenced by Zn2+
[1] and suggests that Zn2+ binding may induce changes in the con-
formation of each lactogen. Data presented in our current work
conﬁrms the hypothesis that Zn2+ induces conformational changes
in each of these hormones and that these changes are unique for
each lactogenic hormone and inﬂuenced by hPRLr binding. A linked
relationship of Zn2+ and hPRLr binding to each of the three lacto-
genic hormones is not surprising when one considers that the
Zn2+ binding site is shared between the hormone and hPRL
receptor.
In contrast to hPRL, neither intrinsic ﬂuorescence nor FRET in
the absence of hPRLr revealed a Zn2+-dependent conformation
change in either hGH or hPL. These observations do not rule out
Zn2+ -induced conformation changes. FRET studies of hGH or hPL
in the presence of hPRLr indicated that Zn2+ was associated with
conformation changes. Functional studies show that Zn2+ changes
both receptor binding [3–5] and biological activities [16] of hGH
and hPL, this may indicate that the effect of Zn2+ is only apparent
when both the hormone and receptor half sites are present or that
the geometry of CPM and the single tryptophan in hGH and hPL
does not allow observation of a Zn2+-induced conformation change.
We investigated this idea by hormone-based FRET assays where
Zn2+ titrations were performed with various stoichiometries of
hPRLr. We observed that each of the three lactogenic hormones
showed a unique Zn2+-induced change in their FRET signal with
sub-saturating or saturating stoichiometries of hPRLr.
When one considers the role that Zn2+ may play in the mecha-
nism of lactogen binding and activation of the hPRL receptor a
complex set of reactions need to be considered. In vivo Zn2+ may
bind each of the lactogens, the hPRL receptor, and each lactogen/
receptor complex. Although the lactogens’ half site binds Zn2+ withmicromolar afﬁnities [2,17], the metal afﬁnities for either the
hPRLr half site or lactogen/receptor complexes have not been
determined. Thus, additional afﬁnities will need to be measured
to understand Zn2+ s role. In target tissues the concentration of
extracellular Zn2+ is largely determined by the serum concentra-
tion. The total serum Zn2+ concentration is believed to be approx-
imately 15 lM [18], but the free zinc concentration is believed to
be in the sub-nanomole range [19]. Our Zn2+ titrations for both
hormones and for hormone/hPRLr complexes were performed in
the lM range and showed a graded response in this concentration
range. This suggests that lactogenic hormones in blood and extra-
cellular ﬂuid may have few molecules bound by zinc. The afﬁnities
of the lactogen/receptor complexes for Zn2+ may be much stronger
than the lM afﬁnity observed for the lactogens’ half sights and
may represent the species where biologically signiﬁcant Zn2+ bind-
ing occurs. Alternatively, in the absence of sufﬁcient Zn2+ concen-
trations to allow hPRL receptor binding, hGH may be restricted
to actions through the hGH receptor. Micromole Zn2+ concentra-
tions promote association with hormones in secretory granules
[20,21]. Perhaps the primary role of Zn2+ is to package and store
these hormones in secretory granules [22].
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